<DOC>
	<DOCNO>NCT00315952</DOCNO>
	<brief_summary>University Pittsburgh Medical Center ( UPMC ) diabetes research physician study action muscle tissue `` inhaled '' insulin ( Exubera® ) `` infuse '' ( intravenous IV ) insulin blood sugar control people type 1 diabetes . Type 1 diabetic often take 2-4 shot insulin every day . Exubera may offer alternative insulin injection .</brief_summary>
	<brief_title>Study Estimate Effects Inhaled Versus Intravenous ( IV ) Infusion Human Insulin Subjects With Type 1 Diabetes</brief_title>
	<detailed_description>A dry powder insulin formulation deliver aerosol inhaler clinical development use type 1 2 diabetes mellitus ( DM ) recently ( 1-27-06 ) receive approval U.S. Food Drug Administration ( FDA ) clinical treatment diabetes . Administration insulin without need subcutaneous ( SC ) injection attractive alternative patient diabetes . There preclinical clinical data indicate inhalation insulin result potent effect glucose disposal lower fast glucose attained equivalent dose SC intravenous ( IV ) insulin . The physiological mechanism ( ) unclear , occur even match pharmacokinetics . The current proposal seek primarily fully delineate whether physiological difference metabolic effect inhale compare IV infused insulin , give IV insulin match pharmacokinetics ( PK ) achieve inhaled insulin . There 3 specific aim : 1 . The first aim establish protocol match PK inhaled insulin PK intravenously infuse insulin . An infusion algorithm develop test refine healthy volunteer ( n = 3-5 ) , use physiological study ( aim ) outline . 2 . The second aim perform Positron Emission Tomography ( PET ) image [ 18F ] -FDG uptake muscle , follow administration single dose inhale compare infused insulin . Volunteers type 1 DM ( n =12 ) study , serve his/her within-subject control , condition insulin administration . In type 1 diabetes mellitus ( type 1 DM ) volunteer , test hypothesis single dose inhale versus infused insulin , match arterial concentration , cause great stimulation muscle glucose uptake . 3 . The third aim determine overnight rate glucose production plasma glucose single pre-dinner dose inhale compare IV infused insulin . The 12 volunteer study Aim 2 study even precede PET image study serve his/her within-subject control , condition insulin administration .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Ages 18 50 year old Body mass index ( BMI ) 20 27 kg/m2 total body weight &gt; 50 kg ( 110 lb ) Blood pressure : systolic &lt; 150 ; diastolic &lt; 95 . Type 1 DM Have diagnose diabetes type 1 minimum 12 month prior study entry In good general health evidence history clinically significant hematological , renal , endocrine ( diabetes ) , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) Hematocrit ( Hct ) &gt; 34 % ALT &lt; 60 ; AST &lt; 60 Alkaline phosphatase ( Alk Phos ) &lt; 150 Sensitive thyroidstimulating hormone ( sTSH ) &lt; 6 Fasting ( morning ) glucose 100160 mg/dl Documented hemoglobin A1c ( HbA1c ) &lt; 7.5 % time entry Triglycerides &lt; 175 Cholesterol &lt; 275 Exclude unable master use inhalation device 3 attempt Exclude positive urine drug screen Exclude episodes severe hypoglycemia past 3 month Exclude pregnant breastfeed unwilling use acceptable method nonhormonal contraception least 14 day prior first dose Exubera® study complete . Exclude history ( h/o ) asthma chronic obstructive pulmonary disease ( COPD ) Exclude forced expiratory volume one second ( FEV1 ) force vital capacity ( FVC ) &lt; 70 % predicted Exclude treatment investigational drug within 30 day precede first dose trial medication . Exclude blood donation approximately 1 pint ( 500 mL ) within 56 day prior dose Exclude unable unwilling comply protocol write Exclude use tobacco nicotine containing product within past 6 month Exclude history regular alcohol consumption exceed 7 drinks/week female 14 drinks/week men ( 1 drink = 5 ounce wine 12 ounce [ 360 mL ] beer 1.5 ounce [ 45 mL ] hard liquor ) within 6 month screen Exclude claustrophobic , surgical vascular implant pacemaker , metal body</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>type 1 diabetes mellitus</keyword>
	<keyword>inhaled insulin</keyword>
	<keyword>Positron Emission Tomography</keyword>
</DOC>